Kyprolis Drug Interactions
Currently displaying 107 drugs known to have a major interaction with Kyprolis (carfilzomib).
- 107 major drug interactions
- 224 moderate drug interactions
Major interactions with Kyprolis (carfilzomib)
Note: Showing generic names only.
A
- abrocitinib
- adalimumab
- allogeneic processed thymus tissue
- aminocaproic acid
- antihemophilic factor
- avatrombopag
B
C
- C1 esterase inhibitor (human)
- certolizumab
- chikungunya vaccine, live (cvx 317)
- chlorotrianisene
- cladribine
- clozapine
- coagulation factor ix
- coagulation factor viia
- coagulation factor x
- coagulation factor Xa
- conestat alfa
- conjugated estrogens
- conjugated estrogens topical
D
- danazol
- darbepoetin alfa
- deferiprone
- dehydroepiandrosterone
- dengue vaccine
- deucravacitinib
- dienestrol topical
- diethylstilbestrol
- drospirenone
E
- eltrombopag
- epoetin alfa
- epoetin beta-methoxy polyethylene glycol
- esterified estrogens
- estradiol
- estradiol topical
- estrone
- estropipate
- estropipate topical
- etanercept
- ethinyl estradiol
- etonogestrel
- etrasimod
F
G
I
K
L
M
N
O
P
Q
R
S
T
- talimogene laherparepvec
- tamoxifen
- teriflunomide
- testolactone
- testosterone
- testosterone topical
- tofacitinib
- toremifene
- tranexamic acid
- typhoid vaccine, live
U
V
Y
Z
Kyprolis alcohol/food interactions
There is 1 alcohol/food interaction with Kyprolis (carfilzomib).
Kyprolis disease interactions
There are 12 disease interactions with Kyprolis (carfilzomib) which include:
- TLS
- cardiac disease
- dyspnea
- hemorrhage
- hepatic toxicity
- hypertension
- PRES
- pulmonary hypertension
- pulmonary toxicity
- renal failure
- TTP/HUS
- venous thrombosis
More about Kyprolis (carfilzomib)
- Kyprolis consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: proteasome inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.